Antiangiogenic Therapy With Pioglitazone, Rofecoxib, and Trofosfamide in a Patient With Endemic Kaposi Sarcoma
Archives of Dermatology
doi 10.1001/archderm.140.12.1504
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2004
Authors
Publisher
American Medical Association (AMA)